"Breakthrough Diabetes Drug Mounjaro: A Powerful Solution for Weight Loss"

A clinical trial has shown that the diabetes drug Mounjaro, also known as tirzepatide, is effective for weight loss, with participants losing an average of 60 pounds. Mounjaro targets two hormones that regulate appetite and fullness, distinguishing it from other weight-loss drugs that target only one hormone. The study included 800 overweight and obese individuals without diabetes, and those who received Mounjaro lost 18.4% more of their body weight compared to those on a placebo. Side effects include nausea, diarrhea, and constipation. The drug has received fast-track review status from the U.S. Food and Drug Administration for the treatment of obesity.